Cell & Gene Therapy Solutions

Harness the power of our GMP-grade cytokines, cell isolation kits, flow cytometry antibodies, and more to advance your cell therapy workflow.

  • Scale up supportOptimize production processes and increase cell numbers to meet the growing demand.

  • On-time deliveryMaintain your production schedule and prevent delays in the preparation of lifesaving therapies.

  • Regulatory complianceEach product meets rigorous quality standards, ensuring the integrity and efficacy of the final therapy.

Featured cell and gene therapy products

GMP-grade antibodies

Extensive portfolio of recombinant GMP-grade antibodies designed to support cell separation, activation, and enrichment across cell and gene therapy workflows. Each antibody is produced in ISO-certified cleanrooms with animal-free components, following USP and WHO guidelines to ensure superior safety, consistency, and reproducibility.

GMP-grade cytokines

Proteintech GMP grade HumanKine growth factors and cytokines are produced in human cells, ensuring the right post-translational modifications required for the highest bioactivity.​

CAR detection reagents

Proteintech provides a comprehensive portfolio of CAR detection reagents optimized for high sensitivity, batch-to-batch consistency, and compatibility with diverse workflows enabling accurate quantification and monitoring of CAR expression. Designed for verification, in-process analytics, and release testing of CAR engineered cell products.

Flow cytometry antibodies

Enhance your research accuracy and efficiency with our comprehensive range of high-quality antibodies conjugated to highly bright CoraLite Plus dyes.

ELISA kits

Ultra sensitive ELISA kits for detection and precise quantification of secretomes of T cells, B cells, NK cells and many more.

Magnetic cell separation kits

Simply incubate your heterogeneous cell suspension with Proteintech’s magnetic cell separation particles to discover quick, easy, column-free cell depletions and isolations, resulting in a high purity homogeneous cell population.

Product data

HumanKine IL-2 demonstrating greater bioactivity and better T cell expansion

Interleukin-2 (IL-2) is a cytokine used for culturing a wide range of leukocytes; inducing proliferation in CD4+ and CD8+ T cells, maintaining normal T regulatory cells function, and is essential in immune homeostasis and self-tolerance.

Proteintech’s HumanKine human cell expressed recombinant IL-2 is up to 40x more active than our leading competitor IL-2 when benchmarked side-by-side in the competitor’s optimized assay protocol. The use of human expression systems in the production of IL-2 ensures that the protein is structurally and functionally optimized for compatibility with the human immune system. This results in a more efficient interaction between Humankine IL-2 and human T cells, leading to heightened bioactivity and increased proliferation rates.

Dose-response curve comparing fold induction of Proteintech IL-2 versus Competitor IL-2 across a concentration range, showing Proteintech IL-2 is ~24x more potent with an EC50 of 0.174 ng/mL compared to the competitor’s EC50 of 4.21 ng/mL.

IL-2 bioactivity Comparison to Leading Competitor
Assay Method: IL-2 induction of CTLL-2 cells (mouse cytotoxic T cell)

Bar chart comparing luminescence (RLU) of HumanKine® IL-2 versus a competitor IL-2 protein under unstimulated and stimulated conditions at 5 and 9 days, showing higher activity for HumanKine® IL-2 in stimulated conditions

Comparison of Humankine IL-2 vs competitor product demonstrating greater levels of γδ T cell expansion and proliferation using HumanKine Il-2

The GMP CD3 (OKT3) antibody delivers performance comparable to the market standard

Proteintech’s GMP-grade CD3(OKT3) antibody demonstrates T cell activation performance equivalent to leading market alternatives. In comparative studies, it induced comparable levels of proliferation and activation marker expression (CD25, CD69), validating its potency and reliability. These findings confirm that GMP CD3 antibody delivers consistent, high-quality performance for T cell activation in cell therapy manufacturing workflows.

Comparison chart of GMP Mouse CD3 (OKT3 clone, D3) from Proteintech versus competitor vendor, showing performance data like staining intensity or purity

Human PBMCs were incubated for 3 days with soluble CD3 (OKT3) Recombinant Monoclonal Antibody (CT-1000-GMP) at 50ng/mL (center), or GMP-grade Anti-Human CD3 (OKT3) Antibody from another vendor at 50ng/mL (right), or cultured in media alone (left). Cells were then stained with Anti-Human CD3 (AB-65151), Anti-Human CD25 (PE-65096), Anti-Human CD69 (APC-FcA98173). Cells were gated on singlets (FSC-H vs FSC-A), live (Phantom Dye-), and CD3+ lymphocytes.

Human Memory/Naïve T Cell Panel for flow cytometry analysis

Characterizing T cell subtypes is critical to optimize methods for T cell expansion during cell therapy developmet. This panel is designed for the separation of T lymphocytes (CD3+) into Helper T Lymphocyte, (CD4+), Cytotoxic T Lymphocyte (CD8+), Naïve T Lymphocytes (CD45RA expressing) and Memory T Lymphocytes (CD45RO expressing). Naïve T cells have not previously encountered an antigen while memory T cells have and can therefore, more quickly respond to subsequent encounters of that antigen.

Flow cytometry gating strategy showing sequential identification of lymphocytes, single cells, CD3+ T lymphocytes, and CD4/CD8 T lymphocyte subpopulations, with CD45RA and CD45RO expression shown for both CD4 and CD8 subsets.

CD8+ Cytotoxic T lymphocytes (left) and CD4+ Helper T lymphocytes (right) were gated and evaluated for CD45RA and CD45RO expression.